Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab
- PMID: 37060261
- DOI: 10.1111/jdv.19116
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab
References
REFERENCES
-
- Buder K, Ruppert S, Trautmann A, Brocker EB, Goebeler M, Kerstan A. Angiolymphoid hyperplasia with eosinophilia and Kimura's disease - a clinical and histopathological comparison. J Dtsch Dermatol Ges. 2014;12(3):224-8.
-
- Adler BL, Krausz AE, Minuti A, Silverberg JI, Lev-Tov H. Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): a systematic review. J Am Acad Dermatol. 2016;74(3):506-12.e11.
-
- Braun-Falco M, Fischer S, Plotz SG, Ring J. Angiolymphoid hyperplasia with eosinophilia treated with anti-interleukin-5 antibody (mepolizumab). Br J Dermatol. 2004;151(5):1103-4.
-
- Grunewald M, Stolzl D, Wehkamp U, Weichenthal M, Kaeding M, Schwarz T, et al. Role of eosinophils in angiolymphoid hyperplasia with eosinophilia. JAMA Dermatol. 2021;157(10):1241-3.
-
- Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 2006;16(1):3-10.
Publication types
LinkOut - more resources
Full Text Sources